weerapatkiatdumrong / iStockphoto.com
South Korea-based Samsung has revealed plans to commit W25 trillion ($22 billion) to pursue new technology in areas including biopharmaceuticals and artificial intelligence (AI).
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Samsung, innovation, new technology, artificial intelligence, biopharma, biosimilars , investment, technology
